MHRAsafety guidance65% confidence
Project Orbis
Source: MHRA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for TAPUR Study Evaluates Targeted Therapies in Advanced Cancer with Genomic Variant.
Regulatory Analysis
Project Orbis is a programme to review and approve promising cancer drugs helping patients access treatments faster.
Supporting Context
- Therapeutic area
- Oncology · Targeted Therapy
- Sub-indication
- General
Related signal: TAPUR Study Evaluates Targeted Therapies in Advanced Cancer with Genomic Variants